[go: up one dir, main page]

AR015917A1 - COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA - Google Patents

COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA

Info

Publication number
AR015917A1
AR015917A1 ARP980103146A ARP980103146A AR015917A1 AR 015917 A1 AR015917 A1 AR 015917A1 AR P980103146 A ARP980103146 A AR P980103146A AR P980103146 A ARP980103146 A AR P980103146A AR 015917 A1 AR015917 A1 AR 015917A1
Authority
AR
Argentina
Prior art keywords
solubility
sertralin
compositions
procedure
matter
Prior art date
Application number
ARP980103146A
Other languages
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR015917(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR015917A1 publication Critical patent/AR015917A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Una composicion de materia que contiene sertralina o una sal farmacéuticamente aceptable y una cantidad de agente solubilizante suficiente para obtener unaconcentracion de sertralina disuelta en un medio de uso que contiene iones cloruro que sea 1,5veces mayor que la concentracion obtenida por una composicioncomparativa de materia idéntica a la anterior pero sin incluir el mencionado agente solubilizante. Un procedimiento para aumentar la solubilidad de lasertralina en un medio acuoso que contiene ion cloruro, anadiendo la mencionada sertralina al mencionado medio de uso en una composicion de materia queadicionalmente comprende un agente solubilizante.A composition of matter containing sertraline or a pharmaceutically acceptable salt and an amount of solubilizing agent sufficient to obtain a concentration of sertraline dissolved in a medium containing chloride ions that is 1.5 times greater than the concentration obtained by a comparative composition of identical matter to the previous one but not including the mentioned solubilizing agent. A process for increasing the solubility of lasertraline in an aqueous medium containing chloride ion, adding said sertraline to said means of use in a composition of matter queditionally comprises a solubilizing agent.

ARP980103146A 1997-07-01 1998-06-29 COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA AR015917A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
AR015917A1 true AR015917A1 (en) 2001-05-30

Family

ID=21971159

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP980103146A AR015917A1 (en) 1997-07-01 1998-06-29 COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA
ARP030102179A AR040279A2 (en) 1997-07-01 2003-06-19 COMPOSITIONS CONTAINING SERTRALINE SALT
ARP030102180A AR040280A2 (en) 1997-07-01 2003-06-19 PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP030102179A AR040279A2 (en) 1997-07-01 2003-06-19 COMPOSITIONS CONTAINING SERTRALINE SALT
ARP030102180A AR040280A2 (en) 1997-07-01 2003-06-19 PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA

Country Status (34)

Country Link
EP (1) EP0999829A1 (en)
JP (1) JP2000514100A (en)
KR (1) KR100366373B1 (en)
CN (1) CN1261794A (en)
AP (1) AP1192A (en)
AR (3) AR015917A1 (en)
AU (1) AU742535B2 (en)
BG (1) BG103918A (en)
BR (1) BR9810739A (en)
CA (1) CA2290974C (en)
CO (1) CO4940495A1 (en)
DZ (1) DZ2548A1 (en)
EA (1) EA002481B1 (en)
HN (1) HN1998000102A (en)
HR (1) HRP980377A2 (en)
HU (1) HUP0002236A3 (en)
ID (1) ID23429A (en)
IL (1) IL133076A (en)
IS (1) IS5260A (en)
MA (1) MA24587A1 (en)
NO (1) NO996520L (en)
OA (1) OA11243A (en)
PA (1) PA8454301A1 (en)
PE (1) PE97199A1 (en)
PL (1) PL337804A1 (en)
SK (1) SK181099A3 (en)
TN (1) TNSN98124A1 (en)
TR (1) TR199903297T2 (en)
TW (1) TW550087B (en)
UA (1) UA67741C2 (en)
UY (1) UY25071A1 (en)
WO (1) WO1999001120A1 (en)
YU (1) YU68299A (en)
ZA (1) ZA985708B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003518485A (en) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク Pharmaceutical composition giving improved drug concentration
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
WO2002017918A2 (en) 2000-08-30 2002-03-07 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
KR101500020B1 (en) * 2007-03-12 2015-03-06 디에스엠 아이피 어셋츠 비.브이. Beauty composition
EP2520299A1 (en) * 2009-12-29 2012-11-07 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
EP2520300A4 (en) * 2009-12-29 2013-05-08 Kowa Co PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
CN109908354A (en) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 Sertraline hydrochloride takes orally concentrate and its preparation process
CN114894736A (en) * 2022-05-20 2022-08-12 中化地质矿山总局地质研究院 A kind of determination method of nitrate in chloride type brine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0415612B1 (en) * 1989-08-30 1993-11-10 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
MA24587A1 (en) 1998-12-31
UY25071A1 (en) 2000-12-29
OA11243A (en) 2003-07-24
UA67741C2 (en) 2004-07-15
EP0999829A1 (en) 2000-05-17
WO1999001120A1 (en) 1999-01-14
PE97199A1 (en) 1999-10-05
IL133076A (en) 2003-12-10
HUP0002236A3 (en) 2003-12-29
EA199900962A1 (en) 2000-08-28
CA2290974A1 (en) 1999-01-14
AU742535B2 (en) 2002-01-03
PA8454301A1 (en) 2000-09-29
BG103918A (en) 2000-07-31
TR199903297T2 (en) 2000-07-21
PL337804A1 (en) 2000-09-11
DZ2548A1 (en) 2003-02-08
AR040280A2 (en) 2005-03-23
JP2000514100A (en) 2000-10-24
YU68299A (en) 2002-06-19
ZA985708B (en) 2000-01-10
IS5260A (en) 1999-11-19
CO4940495A1 (en) 2000-07-24
BR9810739A (en) 2000-09-12
KR20010013365A (en) 2001-02-26
HUP0002236A2 (en) 2003-08-28
AR040279A2 (en) 2005-03-23
CA2290974C (en) 2004-04-27
AP9801280A0 (en) 1998-06-30
TW550087B (en) 2003-09-01
SK181099A3 (en) 2000-07-11
NO996520L (en) 2000-02-29
HN1998000102A (en) 1999-01-08
IL133076A0 (en) 2001-03-19
TNSN98124A1 (en) 2005-03-15
NO996520D0 (en) 1999-12-28
EA002481B1 (en) 2002-06-27
AP1192A (en) 2003-07-23
KR100366373B1 (en) 2003-01-14
ID23429A (en) 2000-04-20
HRP980377A2 (en) 1999-04-30
AU7544898A (en) 1999-01-25
CN1261794A (en) 2000-08-02

Similar Documents

Publication Publication Date Title
AR000714A1 (en) A METHOD OF USE OF A CHELING AGENT TO IMPROVE THE COLOR FIDELITY OF WASHED FABRICS AND A COMPOSITION FOR USE IN SUCH METHOD.
AR010579A1 (en) READY TO USE AQUEOUS CLEANING AND DISINFECTION COMPOSITION AND HARD SURFACE DISINFECTION PROCESS.
ES527150A0 (en) A PROCEDURE FOR THE PREPARATION OF AN AQUEOUS HYDROGEN PEROXIDE DISINFECTANT SOLUTION.
MY122621A (en) Compositions containing a high percent saturation concentration of antibacterial agent
MX9701416A (en) Surface-active formulations.
NO990160L (en) Use of a combination of surfactants, chelating agents and essential oils for effective disinfection
ATE312593T1 (en) SKIN CLEANSER FOR INK REMOVAL
BR9509720A (en) Process for the preparation of small particles comprising an organic compound whose solubility is greater in a first water-miscible solvent than in a second solvent which is aqueous and use of the small particles
CO4750721A1 (en) DETERGENT COMPOUND FOR CLEANING TOILETS, ESPECIALLY IN BLOCKS OF THE TYPE "INSIDE THE TANK" OR "BLOCK OF EDGE
EA199900749A1 (en) PHARMACEUTICAL COMPOSITION
AR015917A1 (en) COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA
ES526823A0 (en) PROCEDURE TO OBTAIN STABLE WATER CLEANING AGENT
ES2131704T3 (en) CLEANING AND DISINFECTION OF CONTACT LENSES.
ES2051461T3 (en) CONTRAST MEDIA.
BG95330A (en) CONTRAST AGENTS
KR930019808A (en) Detergent composition
BG103739A (en) Aqueous pharmaceutical composition containing hard soluble active substance in water
ES2046422T3 (en) ANTIMICROBIAL COMPOSITION AND METHOD OF USE.
ES2082515T3 (en) TOILET COMPOSITIONS.
ES2168113T3 (en) WHITENING DISSOLUTION OF LACTONE / PEROXIDE, WHITENING SYSTEM TO FORM THE SAME AND METHOD OF PREPARATION AND USE OF IT.
AR020703A1 (en) CLEANING BAR OF HARD SURFACES.
JPS5320656A (en) Method of decoloring colored waste water
NZ332907A (en) Toilet cleansing block containing greater than 3% of a binder selected from cellulose binder or gum
ES2144648T3 (en) PREVENTION OF HEMOLYSIS THROUGH SURFACE AGENTS.
ES2196814T3 (en) DISINFECTANT PREPARATION CONTAINING CHLORINE IN ALCOHOL.

Legal Events

Date Code Title Description
FC Refusal